MiniMed Group (MMED) director Brett A. Wall submits Form 3 with no trades

Rhea-AI Filing Summary

MiniMed Group, Inc. director Brett A. Wall filed an initial Form 3 to report his status as an insider of the company. The filing does not list any reportable transactions or derivative positions, indicating that this document serves primarily as a baseline ownership and affiliation disclosure.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Wall Brett A.

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does MiniMed Group (MMED) disclose in this Form 3 filing?

The Form 3 identifies Brett A. Wall as a director of MiniMed Group, Inc. It serves as his initial insider ownership and affiliation report, and does not include any reported transactions or derivative positions in the company’s securities.

Who is the reporting person in MiniMed Group (MMED)'s Form 3?

The reporting person is Brett A. Wall, listed as a director of MiniMed Group, Inc. This establishes him as an insider under SEC rules and triggers ongoing reporting obligations for future transactions in the company’s securities.

Does the MiniMed Group (MMED) Form 3 show any stock transactions?

No, the Form 3 shows no reportable transactions, with buy, sell, acquire, and dispose counts all at zero. It functions only as an initial statement of beneficial ownership and insider status rather than a record of recent trading activity.

Are any derivative securities reported in this MiniMed Group (MMED) Form 3?

No derivative securities are reported; the derivative transaction count and derivative summary are both zero. This indicates that, in this filing, Brett A. Wall did not disclose options, warrants, or other derivative positions tied to MiniMed Group shares.

What does the transaction summary indicate in MiniMed Group (MMED)'s Form 3?

The transaction summary shows zero buys, sells, exercises, gifts, or restructurings, with a neutral net buy/sell direction. This confirms that the filing is purely an initial ownership statement without any concurrent insider trading activity disclosed.